Indexed in Journament
European Journal of Therapeutics
ISSN 2564-7040· EN
Login or register to claim ownership or editorship of this journal.
40.4
050100
The Journament Score is computed from platform statistics — reader engagement,
accessibility, publication timeliness, keyword breadth, community impact and content
distribution — into a single 0–100 figure, recalculated as new articles and metadata
are indexed. Dimensions that cannot be measured for this journal are excluded rather
than estimated. It is independent of the paid AI Quality Analysis, which never
affects this score or the ranking.
Full methodology →
About This Journal
European Journal of Therapeutics (Eur J Ther) is the double-blind peer-reviewed, open-access, international publication organ of the Gaziantep University School of Medicine. The journal is a quarterly publication, published on March, June, September, and December and its publication language is English. European Journal of Therapeutics will be published bi-monthly, commencing in 2024 (February, April, June, August, October and December).
European Journal of Therapeutics aims to contribute to the international literature by publishing original clinical and experimental research articles, short communication, review articles, technical notes, and letters to the editor in the fields of medical sciences. The journal’s target audience includes researchers, physicians and healthcare professionals who are interested or working in in all medical disciplines.
The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice).
Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. The journal should be informed of manuscripts that have been submitted to another journal for evaluation and rejected for publication. The submission of previous reviewer reports will expedite the evaluation process.
Manuscripts that have been presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.
Manuscripts submitted to the European Journal of Therapeutics will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in their fields in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal.
The Editor in Chief is the final authority in the decision-making process for all submissions.
| Short Name | European Journal of Therapeutics |
|---|---|
| Abbreviated Name | Eur J Ther |
| ISSN | 2564-7040 |
| URL | https://eurjther.com/ |
| Author Instructions | https://eurjther.com/index.php/home/about/submissions |
Quality Profile
6 of 12 dimensions measured
This journal
Average of scored journals
Platform statistics — the free Journament Score
AI Quality Analysis — separate paid product, ranks nothing
6 of the 12 dimensions could not be measured for this journal. They are left out entirely rather than plotted as zero, and with 6 dimensions measured there is not enough of a profile to draw as a shape.
Show the numbers
| Dimension | This journal | Corpus average |
|---|---|---|
| Engagement | 30.9 | 30.4 |
| Accessibility | 30.0 | 22.5 |
| Timeliness | 20.0 | 3.0 |
| Diversity | — | 22.7 |
| Innovation | 70.0 | 24.1 |
| Community Impact | 5.0 | 4.2 |
| Content Distribution | 79.6 | 88.7 |
| Content Quality | — | 55.5 |
| Ethics & Transparency | — | 40.2 |
| Editorial Standards | — | 33.4 |
| Publication Regularity | — | 53.2 |
| Geographic Reach | — | 30.8 |
Publications Per Year
Articles (18)
2023
Vol. 29
, No. 2
, pp. 116-122
235 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 135-142
222 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 194-200
221 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 173-178
218 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 168-172
204 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 143-148
199 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 110-115
193 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 155-162
191 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 179-187
184 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 201-207
179 views
DOI
Abstract
2023
Vol. 29
, No. 3
, pp. e10-e11
114 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 208-220
162 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 201-207
179 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 194-200
221 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 188-193
171 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 179-187
184 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 173-178
218 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 168-172
204 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 163-167
112 views
DOI
Abstract
2023
Vol. 29
, No. 2
, pp. 155-162
191 views
DOI
Abstract